Condition

Clear Cell Renal Cell Carcinoma (2)

Stage I Renal Cell Cancer AJCC v6 and v7 (2)

Stage II Renal Cell Cancer AJCC v7 (2)

Stage III Renal Cell Cancer AJCC v7 (2)

Metastatic Renal Cell Carcinoma (1)

Stage IV Renal Cell Cancer AJCC v7 (1)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 1 (1)

phase 3 (1)

Sponsor

National Cancer Institute (NCI) (2)

Collaborator

Cancer and Leukemia Group B (1)

NCIC Clinical Trials Group (1)

Southwest Oncology Group (1)

Intervention

laboratory biomarker analysis (1)

metastasectomy (1)

nephrectomy (1)

nivolumab (1)

placebo (1)

quality-of-life assessment (1)

sorafenib tosylate (1)

sunitinib malate (1)

Study Documents

Intervention Type

biological (1)

drug (1)

other (1)

procedure (1)

Funder Type

NIH (2)

Study Type

Interventional (2)

stage i renal cell cancer ajcc v6 and v7

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer AJCC v6 and v7, Stage II Renal Cell Cancer AJCC v7 Trial in Canada,

Completed

Has Results

Clear Cell Renal Cell Carcinoma
+3 more

Laboratory Biomarker Analysis
+4 more

Birmingham, Alabama
+986 more

Jan 13, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Stage I Renal Cell Cancer AJCC v6 and v7 Trial in New York

Terminated

Clear Cell Renal Cell Carcinoma
+5 more

Metastasectomy
+2 more

New York, New York

Memorial Sloan Kettering Cancer Center

Oct 22, 2020